Skip to main content

ATLAS: High-risk RCC patients might benefit from adjuvant axitinib

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ATLAS: High-risk RCC patients might benefit from adjuvant axitinib

User login

Username

Password

Reset your password

Type	Lead	score